MX2023003506A - Composiciones y métodos para la administración de vasodilatadores. - Google Patents
Composiciones y métodos para la administración de vasodilatadores.Info
- Publication number
- MX2023003506A MX2023003506A MX2023003506A MX2023003506A MX2023003506A MX 2023003506 A MX2023003506 A MX 2023003506A MX 2023003506 A MX2023003506 A MX 2023003506A MX 2023003506 A MX2023003506 A MX 2023003506A MX 2023003506 A MX2023003506 A MX 2023003506A
- Authority
- MX
- Mexico
- Prior art keywords
- vasodilator
- delivery
- compositions
- methods
- iloprost
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940124549 vasodilator Drugs 0.000 title 1
- 239000003071 vasodilator agent Substances 0.000 title 1
- 239000004976 Lyotropic liquid crystal Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 abstract 1
- 229960002240 iloprost Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083150P | 2020-09-25 | 2020-09-25 | |
| PCT/US2021/071589 WO2022067336A1 (en) | 2020-09-25 | 2021-09-24 | Compositions and methods for vasodilator delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023003506A true MX2023003506A (es) | 2023-06-28 |
Family
ID=80845891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023003506A MX2023003506A (es) | 2020-09-25 | 2021-09-24 | Composiciones y métodos para la administración de vasodilatadores. |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2023543037A (ja) |
| MX (1) | MX2023003506A (ja) |
| WO (1) | WO2022067336A1 (ja) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638621B2 (en) * | 2000-08-16 | 2003-10-28 | Lyotropic Therapeutics, Inc. | Coated particles, methods of making and using |
| WO2003000236A1 (en) * | 2001-06-23 | 2003-01-03 | Lyotropic Therapeutics, Inc | Particles with improved solubilization capacity |
| US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
| EP2970369B1 (en) * | 2013-03-14 | 2023-11-22 | TheraSyn Sensors, Inc. | Cholestosome vesicles for incorporation of molecules into chylomicrons |
| ES2933175T3 (es) * | 2016-09-15 | 2023-02-02 | Camurus Ab | Formulaciones de análogos de prostaciclina |
| US11173156B2 (en) * | 2019-06-11 | 2021-11-16 | Chdi Foundation, Inc. | Solid forms of a kynurenine-3-monooxygenase inhibitor |
-
2021
- 2021-09-24 WO PCT/US2021/071589 patent/WO2022067336A1/en active Application Filing
- 2021-09-24 JP JP2023519289A patent/JP2023543037A/ja active Pending
- 2021-09-24 MX MX2023003506A patent/MX2023003506A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022067336A1 (en) | 2022-03-31 |
| JP2023543037A (ja) | 2023-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023003506A (es) | Composiciones y métodos para la administración de vasodilatadores. | |
| NZ600000A (en) | Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions | |
| ZA202207669B (en) | Lipid composition and use thereof for delivery of a therapeutically active agent to endothelium | |
| RU2013117209A (ru) | Буферные глазные композиции и способы их применения | |
| MX2020008173A (es) | Combinacion de un agente antimuscarinico o de uno anticolinergico y acido lipoico, y sus usos. | |
| MX2011013201A (es) | Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion. | |
| CA2776302A1 (en) | Neuropeptide-2 receptor (y-2r) agonists | |
| AU2007279311A1 (en) | Antagonists of endothelial differentiation gene subfamily 3 (Edg-3, S1P3) receptors for prevention and treatment of ocular disorders | |
| MX2023011464A (es) | Inhibidores de la cinasa relacionada con el gen nunca en mitosis a 7 (nek7). | |
| NZ767228A (en) | Kv7 channel activators compositions and methods of use | |
| JP2013508383A (ja) | 瞳孔拡張を調節するための、フェントラミンを含む組成物及び方法 | |
| Subbulakshmi et al. | Prostaglandin analogs in ophthalmology | |
| WO2003068159A3 (en) | Compositions and methods for treating pain using cyclooxygenase-1 inhibitors | |
| MX2019009288A (es) | Formas cristalinas de tebipenem pivoxil, composiciones que incluyen a las mismas, metodos de fabricacion, y metodos de utilizacion. | |
| GR1008483B (el) | Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης | |
| WO2008139170A3 (en) | Transdermal and transmucosal drug delivery enhancers | |
| WO2020262057A1 (ja) | 水性貼付剤 | |
| EP4342897A4 (en) | PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTALLINE FORM THEREOF | |
| ZA202101688B (en) | Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain | |
| MX2023003583A (es) | Forma cristalina del compuesto de piridinilfenilo y metodo de preparacion del mismo. | |
| MX2022010800A (es) | Composiciones y metodos para la administracion de naloxona. | |
| ATE188611T1 (de) | Transdermale zusammensetzung von n-(n-(5-(4- (aminoiminomethyl)phenyl-1-oxopentyl)-l-alpha- aspartyl)-l-phenylalanin oder deren esterderivaten und ihre pharmazeutischverwendbaren salze | |
| MX2023011198A (es) | Una forma cristalina de un compuesto de piridopirazoles sustituido con fluor y metodo de preparacion del mismo. | |
| MX2022011527A (es) | Formulaciones de oligosacaridos de agonistas del receptor opioide kappa. | |
| JP2010513262A5 (ja) |